{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,21]],"date-time":"2026-08-21T13:32:41Z","timestamp":1787319161603,"version":"build-2736575974"},"reference-count":92,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,1,1]],"date-time":"2017-01-01T00:00:00Z","timestamp":1483228800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,1,1]],"date-time":"2017-01-01T00:00:00Z","timestamp":1483228800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2017,12,16]],"date-time":"2017-12-16T00:00:00Z","timestamp":1513382400000},"content-version":"am","delay-in-days":349,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100001711","name":"Schweizerischer Nationalfonds zur F\u00c3\u00b6rderung der Wissenschaftlichen Forschung","doi-asserted-by":"publisher","award":["320000-121998"],"award-info":[{"award-number":["320000-121998"]}],"id":[{"id":"10.13039\/501100001711","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochemical Pharmacology"],"published-print":{"date-parts":[[2017,1]]},"DOI":"10.1016\/j.bcp.2016.07.016","type":"journal-article","created":{"date-parts":[[2016,7,23]],"date-time":"2016-07-23T12:54:37Z","timestamp":1469278477000},"page":"1-9","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"special_numbering":"C","title":["Targeting GH-1 splicing as a novel pharmacological strategy for growth hormone deficiency type II"],"prefix":"10.1016","volume":"124","author":[{"given":"Maria Consolata","family":"Miletta","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christa E.","family":"Fl\u00fcck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Primus-E.","family":"Mullis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bcp.2016.07.016_b0005","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1530\/eje.1.01797","article-title":"Genetic control of growth","volume":"152","author":"Mullis","year":"2005","journal-title":"Eur. J. Endocrinol."},{"key":"10.1016\/j.bcp.2016.07.016_b0010","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1007\/s004390050815","article-title":"The molecular genetics of growth hormone deficiency","volume":"103","author":"Procter","year":"1998","journal-title":"Hum. Genet."},{"key":"10.1016\/j.bcp.2016.07.016_b0015","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1038\/nrendo.2010.147","article-title":"Genetic causes and treatment of isolated growth hormone deficiency-an update","volume":"6","author":"Alatzoglou","year":"2010","journal-title":"Nat. Rev. Endocrinol."},{"key":"10.1016\/j.bcp.2016.07.016_b0020","doi-asserted-by":"crossref","first-page":"3191","DOI":"10.1210\/jc.2008-2783","article-title":"Expanding the spectrum of mutations in GH1 and GHRHR: genetic screening in a large cohort of patients with congenital isolated growth hormone deficiency","volume":"94","author":"Alatzoglou","year":"2009","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.bcp.2016.07.016_b0025","doi-asserted-by":"crossref","first-page":"3877","DOI":"10.1210\/jcem.86.8.7757","article-title":"Isolated GH deficiency with dominant inheritance: new mutations, new insights","volume":"86","author":"Binder","year":"2001","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.bcp.2016.07.016_b0030","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1111\/j.1365-2265.2008.03414.x","article-title":"Genetic screening of a Dutch population with isolated GH deficiency (IGHD)","volume":"70","author":"de Graaff","year":"2009","journal-title":"Clin. Endocrinol. (Oxf)"},{"key":"10.1016\/j.bcp.2016.07.016_b0035","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1210\/en.2002-220847","article-title":"Autosomal dominant growth hormone deficiency disrupts secretory vesicles in vitro and in vivo in transgenic mice","volume":"144","author":"McGuinness","year":"2003","journal-title":"Endocrinology"},{"key":"10.1016\/j.bcp.2016.07.016_b0040","first-page":"132","article-title":"Impact of del32-71-GH (exon 3 skipped GH) on intracellular GH distribution, secretion and cell viability: a quantitative confocal microscopy analysis","volume":"65","author":"Salemi","year":"2006","journal-title":"Horm. Res."},{"key":"10.1016\/j.bcp.2016.07.016_b0045","doi-asserted-by":"crossref","first-page":"4728","DOI":"10.1210\/jc.2009-0746","article-title":"A molecular basis for variation in clinical severity of isolated growth hormone deficiency type II","volume":"94","author":"Hamid","year":"2009","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.bcp.2016.07.016_b0050","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1530\/eje.0.1490091","article-title":"Intrinsic imperfections of endocrine replacement therapy","volume":"149","author":"Romijn","year":"2003","journal-title":"Eur. J. Endocrinol."},{"key":"10.1016\/j.bcp.2016.07.016_b0055","doi-asserted-by":"crossref","first-page":"2089","DOI":"10.1210\/jc.2004-1280","article-title":"Isolated autosomal dominant growth hormone deficiency: an evolving pituitary deficit? A multicenter follow-up study","volume":"90","author":"Mullis","year":"2005","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.bcp.2016.07.016_b0060","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1210\/er.2013-1067","article-title":"Isolated growth hormone deficiency (GHD) in childhood and adolescence: recent advances","volume":"35","author":"Alatzoglou","year":"2014","journal-title":"Endocr. Rev."},{"key":"10.1016\/j.bcp.2016.07.016_b0065","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.ghir.2005.02.005","article-title":"The metabolic role of growth hormone in humans with particular reference to fasting","volume":"15","author":"Norrelund","year":"2005","journal-title":"Growth Horm. IGF Res."},{"key":"10.1016\/j.bcp.2016.07.016_b0070","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1111\/j.1365-2265.2006.02676.x","article-title":"Modulation of growth hormone action by sex steroids","volume":"65","author":"Meinhardt","year":"2006","journal-title":"Clin. Endocrinol. (Oxf)"},{"issue":"Suppl. A","key":"10.1016\/j.bcp.2016.07.016_b0075","article-title":"Reciprocal interactions between the GH axis and sleep","volume":"14","author":"Van Cauter","year":"2004","journal-title":"Growth Horm. IGF Res."},{"key":"10.1016\/j.bcp.2016.07.016_b0080","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1016\/j.ghir.2009.04.023","article-title":"The physiology of growth hormone and sport","volume":"19","author":"Widdowson","year":"2009","journal-title":"Growth Horm. IGF Res."},{"issue":"Suppl. 1","key":"10.1016\/j.bcp.2016.07.016_b0085","doi-asserted-by":"crossref","first-page":"S15","DOI":"10.1530\/EJE-07-0148","article-title":"Genetic disorders in the GH IGF-I axis in mouse and man","volume":"157","author":"Walenkamp","year":"2007","journal-title":"Eur. J. Endocrinol."},{"key":"10.1016\/j.bcp.2016.07.016_b0090","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1002\/humu.10167","article-title":"Human growth hormone 1 (GH1) gene expression: complex haplotype-dependent influence of polymorphic variation in the proximal promoter and locus control region","volume":"21","author":"Horan","year":"2003","journal-title":"Hum. Mutat."},{"key":"10.1016\/j.bcp.2016.07.016_b0095","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1038\/nrg2776","article-title":"Alternative splicing and evolution: diversification, exon definition and function","volume":"11","author":"Keren","year":"2010","journal-title":"Nat. Rev. Genet."},{"key":"10.1016\/j.bcp.2016.07.016_b0100","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1089\/dna.1987.6.59","article-title":"The human growth hormone gene locus: structure, evolution, and allelic variations","volume":"6","author":"Hirt","year":"1987","journal-title":"DNA"},{"key":"10.1016\/j.bcp.2016.07.016_b0105","first-page":"11","article-title":"Genetic basis of endocrine disease. 6. Molecular basis of familial human growth hormone deficiency","volume":"78","author":"Phillips","year":"1994","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.bcp.2016.07.016_b0110","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1126\/science.1549776","article-title":"Human growth hormone and extracellular domain of its receptor: crystal structure of the complex","volume":"255","author":"de Vos","year":"1992","journal-title":"Science"},{"key":"10.1016\/j.bcp.2016.07.016_b0115","first-page":"E101","article-title":"Temporal structure of in vivo growth hormone secretory events in humans","volume":"260","author":"Hartman","year":"1991","journal-title":"Am. J. Physiol."},{"key":"10.1016\/j.bcp.2016.07.016_b0120","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1023\/A:1022579327647","article-title":"Hypothalamic and hypophyseal regulation of growth hormone secretion","volume":"18","author":"Bluet-Pajot","year":"1998","journal-title":"Cell. Mol. Neurobiol."},{"key":"10.1016\/j.bcp.2016.07.016_b0125","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1038\/45230","article-title":"Ghrelin is a growth-hormone-releasing acylated peptide from stomach","volume":"402","author":"Kojima","year":"1999","journal-title":"Nature"},{"key":"10.1016\/j.bcp.2016.07.016_b0130","doi-asserted-by":"crossref","first-page":"4308","DOI":"10.1210\/endo.137.10.8828490","article-title":"Recombinant human growth hormone (GH)-binding protein enhances the growth-promoting activity of human GH in the rat","volume":"137","author":"Clark","year":"1996","journal-title":"Endocrinology"},{"key":"10.1016\/j.bcp.2016.07.016_b0135","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1038\/330537a0","article-title":"Growth hormone receptor and serum binding protein: purification, cloning and expression","volume":"330","author":"Leung","year":"1987","journal-title":"Nature"},{"key":"10.1016\/j.bcp.2016.07.016_b0140","doi-asserted-by":"crossref","first-page":"3879","DOI":"10.1210\/endo.140.9.7066","article-title":"Insulin-like growth factor I \u2013 a prototypic peripheral-paracrine hormone?","volume":"140","author":"Melmed","year":"1999","journal-title":"Endocrinology"},{"key":"10.1016\/j.bcp.2016.07.016_b0145","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1677\/joe.0.1700063","article-title":"The acid-labile subunit (ALS) of the 150kDa IGF-binding protein complex: an important but forgotten component of the circulating IGF system","volume":"170","author":"Boisclair","year":"2001","journal-title":"J. Endocrinol."},{"key":"10.1016\/j.bcp.2016.07.016_b0150","first-page":"761","article-title":"The insulin-like growth factor-binding protein (IGFBP) superfamily","volume":"20","author":"Hwa","year":"1999","journal-title":"Endocr. Rev."},{"key":"10.1016\/j.bcp.2016.07.016_b0155","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.1210\/jcem-70-5-1347","article-title":"Circulating levels and molecular distribution of the acid-labile (alpha) subunit of the high molecular weight insulin-like growth factor-binding protein complex","volume":"70","author":"Baxter","year":"1990","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.bcp.2016.07.016_b0160","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1210\/jcem.87.1.8151","article-title":"Molecular distribution of IGF binding protein-5 in human serum","volume":"87","author":"Baxter","year":"2002","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.bcp.2016.07.016_b0165","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1038\/nrg775","article-title":"Listening to silence and understanding nonsense: exonic mutations that affect splicing","volume":"3","author":"Cartegni","year":"2002","journal-title":"Nat. Rev. Genet."},{"key":"10.1016\/j.bcp.2016.07.016_b0170","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1146\/annurev.biochem.72.121801.161720","article-title":"Mechanisms of alternative pre-messenger RNA splicing","volume":"72","author":"Black","year":"2003","journal-title":"Annu. Rev. Biochem."},{"key":"10.1016\/j.bcp.2016.07.016_b0175","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/S0968-0004(00)01604-2","article-title":"Alternative pre-mRNA splicing: the logic of combinatorial control","volume":"25","author":"Smith","year":"2000","journal-title":"Trends Biochem. Sci."},{"key":"10.1016\/j.bcp.2016.07.016_b0180","doi-asserted-by":"crossref","first-page":"2988","DOI":"10.1210\/en.2003-1724","article-title":"GH1 splicing is regulated by multiple enhancers whose mutation produces a dominant-negative GH isoform that can be degraded by allele-specific small interfering RNA (siRNA)","volume":"145","author":"Ryther","year":"2004","journal-title":"Endocrinology"},{"key":"10.1016\/j.bcp.2016.07.016_b0185","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1007\/s00439-003-0949-x","article-title":"Disruption of exon definition produces a dominant-negative growth hormone isoform that causes somatotroph death and IGHD II","volume":"113","author":"Ryther","year":"2003","journal-title":"Hum. Genet."},{"key":"10.1016\/j.bcp.2016.07.016_b0190","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1210\/jcem.87.2.8236","article-title":"An exon splice enhancer mutation causes autosomal dominant GH deficiency","volume":"87","author":"Moseley","year":"2002","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.bcp.2016.07.016_b0195","doi-asserted-by":"crossref","first-page":"4427","DOI":"10.1210\/jc.2007-0857","article-title":"Exon splice enhancer mutation (GH-E32A) causes autosomal dominant growth hormone deficiency","volume":"92","author":"Petkovic","year":"2007","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.bcp.2016.07.016_b0200","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1002\/humu.10168","article-title":"Novel mutations of the growth hormone 1 (GH1) gene disclosed by modulation of the clinical selection criteria for individuals with short stature","volume":"21","author":"Millar","year":"2003","journal-title":"Hum. Mutat."},{"key":"10.1016\/j.bcp.2016.07.016_b0205","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1093\/hmg\/6.6.909","article-title":"A novel mechanism of aberrant pre-mRNA splicing in humans","volume":"6","author":"Cogan","year":"1997","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.bcp.2016.07.016_b0210","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1210\/jc.2005-1703","article-title":"A novel deletion in the GH1 gene including the IVS3 branch site responsible for autosomal dominant isolated growth hormone deficiency","volume":"91","author":"Vivenza","year":"2006","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.bcp.2016.07.016_b0215","unstructured":"P. Duquesnoy, D. Simon, I. Netchine, F. Dastot, M.L. Sobrier, M. Goosens, Familial isolated growth hormone deficiency with slight height reduction due to a heterozygote mutation in GH gene, in: Program of the 80th Annual Meeting of The Endocrine Society, New Orleans, LA, 1998, pp. P2\u2013202."},{"key":"10.1016\/j.bcp.2016.07.016_b0220","doi-asserted-by":"crossref","first-page":"4243","DOI":"10.1210\/en.2002-220575","article-title":"Prolonged retention after aggregation into secretory granules of human R183H-growth hormone (GH), a mutant that causes autosomal dominant GH deficiency type II","volume":"143","author":"Zhu","year":"2002","journal-title":"Endocrinology"},{"key":"10.1016\/j.bcp.2016.07.016_b0225","doi-asserted-by":"crossref","first-page":"E1575","DOI":"10.1210\/jc.2015-3265","article-title":"IGHD II: a novel GH-1 gene mutation (GH-L76P) severely affects GH folding, stability, and secretion","volume":"100","author":"Miletta","year":"2015","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.bcp.2016.07.016_b0230","first-page":"1261","article-title":"Familial growth hormone deficiency: a model of dominant and recessive mutations affecting a monomeric protein","volume":"79","author":"Cogan","year":"1994","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.bcp.2016.07.016_b0235","doi-asserted-by":"crossref","first-page":"2650","DOI":"10.1210\/en.2009-1280","article-title":"Growth hormone (GH)-releasing hormone increases the expression of the dominant-negative GH isoform in cases of isolated GH deficiency due to GH splice-site mutations","volume":"151","author":"Petkovic","year":"2010","journal-title":"Endocrinology"},{"key":"10.1016\/j.bcp.2016.07.016_b0240","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1530\/eje.0.1470755","article-title":"Isolated GH deficiency (IGHD) type II: imaging of the pituitary gland by magnetic resonance reveals characteristic differences in comparison with severe IGHD of unknown origin","volume":"147","author":"Binder","year":"2002","journal-title":"Eur. J. Endocrinol."},{"key":"10.1016\/j.bcp.2016.07.016_b0245","doi-asserted-by":"crossref","first-page":"4387","DOI":"10.1210\/jc.2007-0684","article-title":"Variable phenotypes in familial isolated growth hormone deficiency caused by a G6664A mutation in the GH-1 gene","volume":"92","author":"Hess","year":"2007","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.bcp.2016.07.016_b0250","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1530\/eje.1.02041","article-title":"Variability of isolated autosomal dominant GH deficiency (IGHD II): impact of the P89L GH mutation on clinical follow-up and GH secretion","volume":"153","author":"Salemi","year":"2005","journal-title":"Eur. J. Endocrinol."},{"key":"10.1016\/j.bcp.2016.07.016_b0255","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1530\/eje.1.02293","article-title":"Evolution of gonadotropin deficiency in a patient with type II autosomal dominant GH deficiency","volume":"155","author":"Turton","year":"2006","journal-title":"Eur. J. Endocrinol."},{"key":"10.1016\/j.bcp.2016.07.016_b0260","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1210\/en.2006-0772","article-title":"Isolated autosomal dominant growth hormone deficiency: stimulating mutant GH-1 gene expression drives GH-1 splice-site selection, cell proliferation, and apoptosis","volume":"148","author":"Salemi","year":"2007","journal-title":"Endocrinology"},{"key":"10.1016\/j.bcp.2016.07.016_b0265","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1210\/jc.2009-1247","article-title":"Growth hormone (GH) deficiency type II: a novel GH-1 gene mutation (GH-R178H) affecting secretion and action","volume":"95","author":"Petkovic","year":"2010","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.bcp.2016.07.016_b0270","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1038\/nature07754","article-title":"On the road to reading the RNA-interference code","volume":"457","author":"Siomi","year":"2009","journal-title":"Nature"},{"key":"10.1016\/j.bcp.2016.07.016_b0275","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1002\/path.2993","article-title":"Silencing disease genes in the laboratory and the clinic","volume":"226","author":"Watts","year":"2012","journal-title":"J. Pathol."},{"key":"10.1016\/j.bcp.2016.07.016_b0280","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1210\/en.2007-1360","article-title":"Rescue of pituitary function in a mouse model of isolated growth hormone deficiency type II by RNA interference","volume":"149","author":"Shariat","year":"2008","journal-title":"Endocrinology"},{"key":"10.1016\/j.bcp.2016.07.016_b0285","doi-asserted-by":"crossref","first-page":"1188","DOI":"10.1261\/rna.28106","article-title":"Off-target effects by siRNA can induce toxic phenotype","volume":"12","author":"Fedorov","year":"2006","journal-title":"RNA"},{"key":"10.1016\/j.bcp.2016.07.016_b0290","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1038\/nature04791","article-title":"Fatality in mice due to oversaturation of cellular microRNA\/short hairpin RNA pathways","volume":"441","author":"Grimm","year":"2006","journal-title":"Nature"},{"key":"10.1016\/j.bcp.2016.07.016_b0295","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/S0079-6123(09)17513-1","article-title":"Gene therapy for neurodegenerative diseases based on lentiviral vectors","volume":"175","author":"Nanou","year":"2009","journal-title":"Prog. Brain Res."},{"key":"10.1016\/j.bcp.2016.07.016_b0300","doi-asserted-by":"crossref","first-page":"4400","DOI":"10.1210\/en.2010-0196","article-title":"Isolated GH deficiency type II: knockdown of the harmful Delta3GH recovers wt-GH secretion in rat tumor pituitary cells","volume":"151","author":"Lochmatter","year":"2010","journal-title":"Endocrinology"},{"key":"10.1016\/j.bcp.2016.07.016_b0305","doi-asserted-by":"crossref","first-page":"13212","DOI":"10.1073\/pnas.0506306102","article-title":"A lentiviral microRNA-based system for single-copy polymerase II-regulated RNA interference in mammalian cells","volume":"102","author":"Stegmeier","year":"2005","journal-title":"Proc. Nat. Acad. Sci. U.S.A."},{"key":"10.1016\/j.bcp.2016.07.016_b0310","doi-asserted-by":"crossref","first-page":"1730","DOI":"10.1038\/sj.gt.3301893","article-title":"Lentiviruses in gene therapy clinical research","volume":"9","author":"Connolly","year":"2002","journal-title":"Gene Ther."},{"key":"10.1016\/j.bcp.2016.07.016_b0315","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1002\/wrna.1158","article-title":"Targeting RNA splicing for disease therapy","volume":"4","author":"Havens","year":"2013","journal-title":"Wiley Interdiscip. Rev. RNA"},{"key":"10.1016\/j.bcp.2016.07.016_b0320","doi-asserted-by":"crossref","first-page":"1911","DOI":"10.2165\/11315680-000000000-00000","article-title":"Histone deacetylase inhibitors: current status and overview of recent clinical trials","volume":"69","author":"Ma","year":"2009","journal-title":"Drugs"},{"key":"10.1016\/j.bcp.2016.07.016_b0325","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/S0168-9525(01)02619-1","article-title":"Splicing regulation as a potential genetic modifier","volume":"18","author":"Nissim-Rafinia","year":"2002","journal-title":"Trends Genet."},{"key":"10.1016\/j.bcp.2016.07.016_b0330","doi-asserted-by":"crossref","first-page":"9808","DOI":"10.1073\/pnas.171105098","article-title":"Treatment of spinal muscular atrophy by sodium butyrate","volume":"98","author":"Chang","year":"2001","journal-title":"Proc. Nat. Acad. Sci. U.S.A."},{"key":"10.1016\/j.bcp.2016.07.016_b0335","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1038\/sj.embor.7400273","article-title":"Restoration of the cystic fibrosis transmembrane conductance regulator function by splicing modulation","volume":"5","author":"Nissim-Rafinia","year":"2004","journal-title":"EMBO Rep."},{"key":"10.1016\/j.bcp.2016.07.016_b0340","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1002\/humu.9431","article-title":"A new large CFTR rearrangement illustrates the importance of searching for complex alleles","volume":"27","author":"Niel","year":"2006","journal-title":"Hum. Mutat."},{"key":"10.1016\/j.bcp.2016.07.016_b0345","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1210\/jc.2002-020269","article-title":"A novel IVS2 -2A>T splicing mutation in the GH-1 gene in familial isolated growth hormone deficiency type II in the spectrum of other splicing mutations in the Russian population","volume":"88","author":"Fofanova","year":"2003","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.bcp.2016.07.016_b0350","doi-asserted-by":"crossref","first-page":"1491","DOI":"10.1093\/hmg\/7.9.1491","article-title":"Characterization of an intron splice enhancer that regulates alternative splicing of human GH pre-mRNA","volume":"7","author":"McCarthy","year":"1998","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.bcp.2016.07.016_b0355","doi-asserted-by":"crossref","DOI":"10.1210\/en.2015-2038","article-title":"Rescue of isolated growth hormone deficiency type II (IGHD II) via pharmacologic modulation of GH-1 splicing","author":"Miletta","year":"2016","journal-title":"Endocrinology"},{"key":"10.1016\/j.bcp.2016.07.016_b0360","doi-asserted-by":"crossref","first-page":"23619","DOI":"10.1074\/jbc.M710175200","article-title":"Growth hormone deficiency and splicing fidelity: two serine\/arginine-rich proteins, ASF\/SF2 and SC35, act antagonistically","volume":"283","author":"Solis","year":"2008","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bcp.2016.07.016_b0365","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1016\/0277-5379(87)90109-X","article-title":"Clinical pharmacology of sodium butyrate in patients with acute leukemia","volume":"23","author":"Miller","year":"1987","journal-title":"Eur. J. Cancer Clin. Oncol."},{"key":"10.1016\/j.bcp.2016.07.016_b0370","doi-asserted-by":"crossref","first-page":"11218","DOI":"10.1073\/pnas.0801661105","article-title":"A high-throughput screening strategy identifies cardiotonic steroids as alternative splicing modulators","volume":"105","author":"Stoilov","year":"2008","journal-title":"Proc. Nat. Acad. Sci. U.S.A."},{"key":"10.1016\/j.bcp.2016.07.016_b0375","doi-asserted-by":"crossref","first-page":"18551","DOI":"10.1073\/pnas.0903234106","article-title":"Pentamidine reverses the splicing defects associated with myotonic dystrophy","volume":"106","author":"Warf","year":"2009","journal-title":"Proc. Nat. Acad. Sci. U.S.A."},{"key":"10.1016\/j.bcp.2016.07.016_b0380","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1002\/ajh.23725","article-title":"A double-blind, placebo-controlled phase II study of the efficacy and safety of 2,2-dimethylbutyrate (HQK-1001), an oral fetal globin inducer, in sickle cell disease","volume":"89","author":"Reid","year":"2014","journal-title":"Am. J. Hematol."},{"key":"10.1016\/j.bcp.2016.07.016_b0385","doi-asserted-by":"crossref","first-page":"1956","DOI":"10.1182\/blood-2013-11-538470","article-title":"A phase 2 trial of HQK-1001 in HbE-beta thalassemia demonstrates HbF induction and reduced anemia","volume":"123","author":"Patthamalai","year":"2014","journal-title":"Blood"},{"key":"10.1016\/j.bcp.2016.07.016_b0390","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1038\/35106079","article-title":"Histone deacetylases and cancer: causes and therapies","volume":"1","author":"Marks","year":"2001","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.bcp.2016.07.016_b0395","first-page":"2292","article-title":"A phase I dose escalation and bioavailability study of oral sodium phenylbutyrate in patients with refractory solid tumor malignancies","volume":"7","author":"Gilbert","year":"2001","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.bcp.2016.07.016_b0400","first-page":"1584","article-title":"Initiation of growth arrest and apoptosis of MCF-7 mammary carcinoma cells by tributyrin, a triglyceride analogue of the short-chain fatty acid butyrate, is associated with mitochondrial activity","volume":"59","author":"Heerdt","year":"1999","journal-title":"Cancer Res."},{"key":"10.1016\/j.bcp.2016.07.016_b0405","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1146\/annurev.pharmtox.010909.105654","article-title":"RNA targeting therapeutics: molecular mechanisms of antisense oligonucleotides as a therapeutic platform","volume":"50","author":"Bennett","year":"2010","journal-title":"Annu. Rev. Pharmacol. Toxicol."},{"key":"10.1016\/j.bcp.2016.07.016_b0410","doi-asserted-by":"crossref","first-page":"1625","DOI":"10.1093\/hmg\/ddr600","article-title":"A single administration of morpholino antisense oligomer rescues spinal muscular atrophy in mouse","volume":"21","author":"Porensky","year":"2012","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.bcp.2016.07.016_b0415","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1038\/nature10485","article-title":"Peripheral SMN restoration is essential for long-term rescue of a severe spinal muscular atrophy mouse model","volume":"478","author":"Hua","year":"2011","journal-title":"Nature"},{"key":"10.1016\/j.bcp.2016.07.016_b0420","first-page":"379","article-title":"Cellular distribution of phosphorothioate oligodeoxynucleotides in normal rodent tissues","volume":"77","author":"Butler","year":"1997","journal-title":"Lab. Invest."},{"key":"10.1016\/j.bcp.2016.07.016_b0425","doi-asserted-by":"crossref","first-page":"4114","DOI":"10.1073\/pnas.0633863100","article-title":"Bifunctional antisense oligonucleotides provide a trans-acting splicing enhancer that stimulates SMN2 gene expression in patient fibroblasts","volume":"100","author":"Skordis","year":"2003","journal-title":"Proc. Nat. Acad. Sci. U.S.A."},{"key":"10.1016\/j.bcp.2016.07.016_b0430","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1038\/mt.2011.232","article-title":"Bifunctional RNAs targeting the intronic splicing silencer N1 increase SMN levels and reduce disease severity in an animal model of spinal muscular atrophy","volume":"20","author":"Osman","year":"2012","journal-title":"Mol. Ther."},{"key":"10.1016\/j.bcp.2016.07.016_b0435","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1093\/hmg\/ddn382","article-title":"Rescue of a severe mouse model for spinal muscular atrophy by U7 snRNA-mediated splicing modulation","volume":"18","author":"Meyer","year":"2009","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.bcp.2016.07.016_b0440","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1038\/nsb887","article-title":"Correction of disease-associated exon skipping by synthetic exon-specific activators","volume":"10","author":"Cartegni","year":"2003","journal-title":"Nat. Struct. Biol."},{"key":"10.1016\/j.bcp.2016.07.016_b0445","doi-asserted-by":"crossref","first-page":"3203","DOI":"10.1016\/j.bmcl.2010.03.109","article-title":"Clinical status of duplex RNA","volume":"20","author":"Watts","year":"2010","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.bcp.2016.07.016_b0450","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1089\/hum.2008.007","article-title":"The business of RNAi therapeutics","volume":"19","author":"Haussecker","year":"2008","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.bcp.2016.07.016_b0455","doi-asserted-by":"crossref","first-page":"1959","DOI":"10.1038\/jid.2012.101","article-title":"Spliceosome-mediated trans-splicing: the therapeutic cut and paste","volume":"132","author":"Wally","year":"2012","journal-title":"J. Invest. Dermatol."},{"key":"10.1016\/j.bcp.2016.07.016_b0460","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1016\/j.ymthe.2005.09.006","article-title":"Spliceosome-mediated RNA trans-splicing","volume":"12","author":"Yang","year":"2005","journal-title":"Mol. Ther."}],"container-title":["Biochemical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006295216301927?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006295216301927?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,13]],"date-time":"2025-09-13T12:59:33Z","timestamp":1757768373000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006295216301927"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,1]]},"references-count":92,"alternative-id":["S0006295216301927"],"URL":"https:\/\/doi.org\/10.1016\/j.bcp.2016.07.016","relation":{},"ISSN":["0006-2952"],"issn-type":[{"value":"0006-2952","type":"print"}],"subject":[],"published":{"date-parts":[[2017,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Targeting GH-1 splicing as a novel pharmacological strategy for growth hormone deficiency type II","name":"articletitle","label":"Article Title"},{"value":"Biochemical Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bcp.2016.07.016","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}